Ocuphire Pharma (OCUP) Revenue & Revenue Breakdown
Ocuphire Pharma Revenue Highlights
Latest Revenue (Y)
$19.05M
Latest Revenue (Q)
$1.11M
Ocuphire Pharma Revenue by Period
Ocuphire Pharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $19.05M | -52.20% |
2022-12-31 | $39.85M | 6665.70% |
2021-12-31 | $589.00K | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2007-12-31 | - | 100.00% |
2006-12-31 | - | -100.00% |
2005-12-31 | $190.61K | - |
Ocuphire Pharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $1.11M | -35.01% |
2024-03-31 | $1.71M | 1.18% |
2023-12-31 | $1.69M | -85.83% |
2023-09-30 | $11.94M | 224.85% |
2023-06-30 | $3.67M | 110.06% |
2023-03-31 | $1.75M | -95.61% |
2022-12-31 | $39.85M | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | -100.00% |
2021-12-31 | $-589.00K | -220.45% |
2021-09-30 | $489.00K | 389.00% |
2021-06-30 | $100.00K | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | -100.00% |
2020-03-31 | $1.15M | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-09-30 | - | - |
Ocuphire Pharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RIGL | Rigel Pharmaceuticals | $116.88M | $55.31M |
FBIO | Fortress Biotech | $59.66M | $14.63M |
EYPT | EyePoint Pharmaceuticals | $46.02M | $10.52M |
OCUP | Ocuphire Pharma | $19.05M | $1.11M |
CKPT | Checkpoint Therapeutics | $103.00K | - |
EYEN | Eyenovia | $3.79K | $1.63K |
MBIO | Mustang Bio | - | - |
RVPH | Reviva Pharmaceuticals | - | - |
CGTX | Cognition Therapeutics | - | - |
KOD | Kodiak Sciences | - | - |
SLS | SELLAS Life Sciences Group | - | - |
RNAZ | TransCode Therapeutics | - | - |